Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-02 Sale | 2022-09-07 4:50 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,320 | $17.01 | $22,458 | 110,858 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:24 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 725 | $14.96 | $10,847 | 37,975 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:17 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 532 | $14.96 | $7,960 | 87,739 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:16 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,145 | $14.96 | $17,130 | 60,204 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 5:15 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 725 | $14.96 | $10,847 | 102,975 (Direct) | View |
| 2022-08-17 Sale | 2022-08-19 4:58 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,797 | $14.96 | $26,890 | 203,261 (Direct) | View |
| 2022-03-09 Sale | 2022-03-11 4:56 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $17.07 | $170,693 | 114,670 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 5:00 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $18.07 | $108,424 | 2,234 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 4:56 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $18.07 | $90,328 | 32,969 (Direct) | View |
| 2021-10-01 Sale | 2021-10-04 4:57 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $17.18 | $171,841 | 124,670 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 7:55 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $20.52 | $102,579 | 37,969 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 7:55 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $20.52 | $123,134 | 8,234 (Direct) | View |
| 2021-07-01 Sale | 2021-07-02 5:35 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 10,000 | $24.15 | $241,477 | 134,670 (Direct) | View |
| 2021-06-17 Sale | 2021-06-22 5:15 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 1,067 | $30.04 | $32,051 | 144,670 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 7:29 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 8,933 | $30.05 | $268,480 | 145,737 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 6:28 pm | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 7,500 | $26.83 | $201,221 | 22,596 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 6:26 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 34,000 | $26.72 | $908,361 | 14,234 (Direct) | View |
| 2021-05-03 Sale(A) | 2021-05-07 6:05 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $24.84 | $149,051 | 48,234 (Direct) | View |
| 2021-05-03 Sale | 2021-05-06 8:06 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 5,000 | $24.84 | $124,197 | 42,969 (Direct) | View |
| 2021-05-03 Sale | 2021-05-06 8:03 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $24.84 | $149,051 | 74,489 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-02 Gift | 2022-09-07 4:50 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 6,500 | $0 | 110,858 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:24 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 2,418 | $0 | 37,975 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:17 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 1,773 | $0 | 87,739 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:16 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 1,773 | $0 | 60,204 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 5:15 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 2,418 | $0 | 102,975 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-19 4:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 5,805 | $0 | 203,261 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 4:18 pm | N/A 2032-05-25 | KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 5:00 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer | 64,500 | $0 | 64,500 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:59 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 25,800 | $0 | 25,800 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:58 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 47,300 | $0 | 47,300 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:57 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 47,300 | $0 | 47,300 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:56 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 64,500 | $0 | 64,500 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:55 pm | N/A 2032-05-16 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 154,800 | $0 | 154,800 (Direct) | View |
| 2022-01-07 Exercise | 2022-01-11 4:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 33,800 | $7.07 | 87,834 (Direct) | View |
| 2022-01-07 Exercise | 2022-01-11 4:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 23,857 | $8.21 | 87,834 (Direct) | View |
| 2022-01-07 Exercise | 2022-01-11 4:42 pm | N/A 2027-05-24 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 57,657 | $0 | 87,834 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 4:53 pm | N/A 2031-09-29 | KalVista Pharmaceuticals Inc. | KALV | Edwards Martin Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-01 4:58 pm | N/A 2031-09-29 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-01 4:56 pm | N/A 2031-09-29 | KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-01 4:55 pm | N/A 2031-09-29 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-01 4:53 pm | N/A 2031-09-29 | KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 6:28 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 7,500 | $8.39 | 22,596 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 6:28 pm | N/A 2026-11-21 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 7,500 | $0 | 22,596 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:29 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Smith Michael David VP | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:28 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:26 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:25 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-05-26 Gift | 2021-05-28 5:23 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 4,750 | $0 | 354,670 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:23 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 200,000 | $0 | 354,670 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 5:20 pm | N/A 2031-05-25 | KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-06 8:03 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $10.21 | 74,489 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-06 8:03 pm | N/A 2026-11-27 | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer | 6,000 | $0 | 74,489 (Direct) | View |